Abstract
Serum levels of progesterone, cortisol and phenytoin as well as the excretion of 17-OHCS were determined in 45 male epileptics before and during 24 months of the therapy. A significant decrease of the hormones was found in untreated patients. Phenytoin administration caused further decrease of cortisol and its metabolite 17-OHCS levels and a compensation of progesterone serum concentration.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abbott R. J., Browning M. C., Davidson D. L. Serum prolactin and cortisol concentrations after grand mal seizures. J Neurol Neurosurg Psychiatry. 1980 Feb;43(2):163–167. doi: 10.1136/jnnp.43.2.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Asfeldt V. H., Buhl J. Inhibitory effect of diphenylhydantoin on the feedback control of corticotrophin release. Acta Endocrinol (Copenh) 1969 Jul;61(3):551–560. doi: 10.1530/acta.0.0610551. [DOI] [PubMed] [Google Scholar]
- Cavallo A., Moore D. C., Nahori A., Beaumanoir A., Sizonenko P. C. Plasma prolactin and cortisol concentrations in epileptic patients during the night. Arch Neurol. 1984 Nov;41(11):1179–1182. doi: 10.1001/archneur.1984.04050220077018. [DOI] [PubMed] [Google Scholar]
- Choi Y., Thrasher K., Werk E. E., Jr, Sholiton L. J., Olinger C. Effect of diphenylhydantoin on cortisol kinetics in humans. J Pharmacol Exp Ther. 1971 Jan;176(1):27–34. [PubMed] [Google Scholar]
- Gallagher B. B., Murvin A., Flanigin H. F., King D. W., Luney D. Pituitary and adrenal function in epileptic patients. Epilepsia. 1984 Dec;25(6):683–689. doi: 10.1111/j.1528-1157.1984.tb03477.x. [DOI] [PubMed] [Google Scholar]
- Herzog A. G., Russell V., Vaitukaitis J. L., Geschwind N. Neuroendocrine dysfunction in temporal lobe epilepsy. Arch Neurol. 1982 Mar;39(3):133–135. doi: 10.1001/archneur.1982.00510150003001. [DOI] [PubMed] [Google Scholar]
- KRIEGER D. T. Effect of diphenylhydantoin on pituitary-adrenal interrelations. J Clin Endocrinol Metab. 1962 May;22:490–493. doi: 10.1210/jcem-22-5-490. [DOI] [PubMed] [Google Scholar]
- Olesen O. V. Determination of phenobarbital and phenytoin in serum by ultraviolet spectrophotometry. Scand J Clin Lab Invest. 1967;20(1):63–69. [PubMed] [Google Scholar]
- Olsson R., Hellner L., Lindstedt G., Lundberg P. A., Teger-Nilsson A. C. Plasma proteins in patients on long-term antiepileptic treatment. Clin Chem. 1983 Apr;29(4):728–730. [PubMed] [Google Scholar]
- Rogozea R., Florea-Ciocoiu V., Bălăiţ C., Luca N. Interrelation at plasmatic level between antiepileptic drugs and lipids. Its implications in the efficiency of treatment in epilepsy. III. Changes induced by phenobarbital or/and diphenylhydantoin in serum lipids, lipoproteins and cortisol. Neurol Psychiatr (Bucur) 1982 Apr-Jun;20(2):89–100. [PubMed] [Google Scholar]
- Rościszewska D., Buntner B. Ilości wydalanych w moczu 17-hydroksykortykosterydów oraz 17-ketosterydów przez kobiety z napadami padaczkowymi w okresie poprzedzajacym krwawienie miesiaczkowe. Neurol Neurochir Pol. 1975 May-Jun;9(3):305–309. [PubMed] [Google Scholar]
- WERK E. E., Jr, MACGEE J., SHOLITON L. J. EFFECT OF DIPHENYLHYDANTOIN ON CORTISOL METABOLISM IN MAN. J Clin Invest. 1964 Sep;43:1824–1835. doi: 10.1172/JCI105056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Werk E. E., Jr, Choi Y., Sholiton L., Olinger C., Haque N. Interference in the effect of dexamethasone by diphenylhydantoin. N Engl J Med. 1969 Jul 3;281(1):32–34. doi: 10.1056/NEJM196907032810108. [DOI] [PubMed] [Google Scholar]